徐冉驰

冉驰 徐 is currently the Clinical Pharmacology Lead at Biogen, where they oversee clinical pharmacology efforts in China. Previously, they served as the Deputy Director of Translational Medicine at 石药控股集团有限公司, leading early clinical trials in endocrine and autoimmune fields. Their expertise encompasses the design and management of clinical trials across various phases, including oncology projects. They also held the position of Principal Research Scientist at Frontage Laboratories, where they were responsible for clinical sample analysis and study management.